BLOG

Tuesday, April 14, 2020

Lupin extends gain into sixth session as Mandideep unit gets EIR from USFDA

The stock of the drug maker has rallied 47 per cent in the past six trading days, and was quoting close to its 52-week high level of Rs 882

from Home Page https://ift.tt/3bcgC0R
via IFTTT

No comments:

Post a Comment

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...